Dr. Ghione is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
530 East 74th Street
New York, NY 10021
Summary
- Dr. Paola Ghione is a hematologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from University of Torino Faculty of Medicine and has been in practice 9 years. She specializes in Diffuse large B-cell lymphoma, follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, cutaneous lymphomas, hodgkin's lymphoma, T cell lymphoma.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2020
University of Torino Faculty of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2023 - Present
NY State Medical License 2020 - 2026
Clinical Trials
- Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma Start of enrollment: 2020 Jul 08
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.Pallawi Torka, Tatyana Feldman, Kerry J Savage, Nivetha Ganesan, Esther Drill
Journal of Clinical Oncology. 2024-12-11 - Central nervous system lymphomas-Assessment and treatment and prevention of central nervous system relapse.Paola Ghione, Katharine L Lewis, Sabela Bobillo, Laksmi Nayak, Elisabeth Schorb
Hematological Oncology. 2024-11-01 - Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes.Jennifer K Lue, Efrat Luttwak, Alfredo Rivas-Delgado, Helen Irawan, Alexander Boardman
Blood Cancer Journal. 2024-10-14
Abstracts/Posters
- Final Results of a Phase II Biomarker-Driven Study of Ruxolitinib in Relapsed and Refractory T-Cell LymphomaPaola Ghione, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of ...Paola Ghione, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Contemporary Outcomes in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: Single-Institution ExperiencePaola Ghione, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3,546 women prospectively followed after receiving textured breast implants.ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Incidence of Delayed Seromas and Related Risk of Bia-ALCL in a Cohort of 3521 Breast Cancer Women with Textured Implants Prospectively Followed Long Term61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
